Potential for Inhaled Nitric Oxide and Ventilation-Perfusion Mismatch by Electrical Impedance Tomography in the ARDS Patients With Lung Recruitment

Sponsor
Far Eastern Memorial Hospital (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04776408
Collaborator
(none)
100
1
2
8.1
12.4

Study Details

Study Description

Brief Summary

In the recent years, the treatment of Acute Respiratory Distress Syndrome has been proved that lung recruitment re-opens the non-ventilated alveolar to improve ventilation, and inhaled Nitric Oxide dilates non-perfused pulmonary vascular to improve perfusion. Both of these could improve ventilation-perfusion mismatch to enhance oxygenation. However, Ventilation-Perfusion mismatch is devided into ventilated nonperfused lung units(dead space) or perfused nonventilated units(shunt). No published study has evaluated the availability of lung recruitment combined with inhaled Nitric oxide in patients with ARDS.

The aims of our study are to measure dead space or shunt fraction before and after inhaled Nitric Oxide in moderate to severe Acute Respiratory Distress Syndrome patients indicated Nitric oxide in FEMH MICU on 2021/01-2022/12, injected a bolus of 10mL of 3% NaCl solution via the central venous catheter with two-step recruitment maneuver by Electrical Impedance Tomography, which monitors ventilation-perfusion mismatch to evaluate whether the patient has potential to improve V/Q mismatch by Nitric oxide.

Condition or Disease Intervention/Treatment Phase
  • Device: Lung recruitment combined inhaled Nitric oxide
  • Device: Lung recruitment
N/A

Detailed Description

Normally, pulmonary arteries in areas of alveolar hypoxia will constrict as a physiologic response to preserve ventilation/perfusion (V¬/Q¬) matching. However, in ARDS, this normal vasoconstrictive response is impaired. Because the body is unable to shunt blood away from the diseased alveoli, these nonaerated alveoli receive excessive blood flow, which contributes to severe V¬/Q¬ mismatching and an intrapulmonary right-to-left shunting of blood flow, which causes hypoxemia.

In the recent years, the treatment of Acute Respiratory Distress Syndrome has been proved that lung recruitment re-opens the non-ventilated alveolar to improve ventilation, and inhaled Nitric Oxide dilates non-perfused pulmonary vascular to improve perfusion. Both of these could improve ventilation-perfusion mismatch to enhance oxygenation. However, Ventilation-Perfusion mismatch is devided into ventilated nonperfused lung units(dead space) or perfused nonventilated units(shunt). No published study has evaluated the availability of lung recruitment combined with inhaled Nitric oxide in patients with ARDS.

The aims of our study are to measure dead space or shunt fraction before and after inhaled Nitric Oxide in moderate to severe Acute Respiratory Distress Syndrome patients indicated Nitric oxide in FEMH MICU on 2021/01-2022/12, injected a bolus of 10mL of 3% NaCl solution via the central venous catheter with two-step recruitment maneuver by Electrical Impedance Tomography, which monitors ventilation-perfusion mismatch to evaluate whether the patient has potential to improve V/Q mismatch by Nitric oxide.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Moderate to severe ARDS patient on mechanical ventilation in Far Eastern Memorial Hospital MICUModerate to severe ARDS patient on mechanical ventilation in Far Eastern Memorial Hospital MICU
Masking:
Single (Participant)
Masking Description:
During this period, all patients were total sedation using continuous infusion, to prevent any spontaneous breathing .All patients were ventilated using a ventilator
Primary Purpose:
Treatment
Official Title:
Potential for Inhaled Nitric Oxide and Ventilation-Perfusion Mismatch by Electrical Impedance Tomography in the Acute Respiratory Distress Syndrome Patients With Lung Recruitment
Actual Study Start Date :
Apr 29, 2022
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control group_Use Lung recruitment

Use the Lung recruitment,

Device: Lung recruitment
Ventilator and Electrical Impedance Tomography monitor the V/Q mismatch

Experimental: Study group_Use Lung recruitment combined inhaled Nitric oxide

Use the Lung recruitment combined inhaled Nitric oxide,

Device: Lung recruitment combined inhaled Nitric oxide
Ventilator combined inhaled Nitric oxide and Electrical Impedance Tomography monitor the V/Q mismatch

Outcome Measures

Primary Outcome Measures

  1. V/Q mismatch [15 minutes]

    Compare the V/Q mismatch between two groups

Secondary Outcome Measures

  1. PaO2/FiO2 ratio improvement rate [15 minutes]

    Oxygention improve rate

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Moderate to severe ARDS patient on mechanical ventilation in MICU. (P/F≦ 200 with PEEP ≥ 5cmH20) (PEEP greater than or equal to 5 cm H2O and Berlin criteria for ARDS)
Exclusion Criteria:
  • Hemodynamic instability or severe COPD, pulmonary embolism

  • Acute brain injury, seizure attack, AMI, AIDS, severe arrhythmia

  • On pacemaker

  • Pregnant

  • Thoracic trauma or burn injury

  • Pneumothorax

Contacts and Locations

Locations

Site City State Country Postal Code
1 Far Eastern Memorial Hospital Taipei county Banqiao Dist Taiwan 22060

Sponsors and Collaborators

  • Far Eastern Memorial Hospital

Investigators

  • Study Director: Hou T Chang, Doctor, Far Eastern Memorial Hospital
  • Study Director: Ping H Wang, Bachelor, Far Eastern Memorial Hospital
  • Study Director: Mei Y Chang, Master, Far Eastern Memorial Hospital

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT04776408
Other Study ID Numbers:
  • 109200-F
First Posted:
Mar 1, 2021
Last Update Posted:
May 9, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Far Eastern Memorial Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 9, 2022